Finger Joint Contractures 5 Years After Treatment for Dupuytren Disease: A Comparative Cohort Study of Collagenase Injection Versus Surgical Fasciectomy
- PMID: 35868901
- DOI: 10.1016/j.jhsa.2022.04.019
Finger Joint Contractures 5 Years After Treatment for Dupuytren Disease: A Comparative Cohort Study of Collagenase Injection Versus Surgical Fasciectomy
Abstract
Purpose: To compare collagenase injection with surgical fasciectomy in Dupuytren disease (DD) for the prevalence of contracture in treated fingers 5 years after treatment.
Methods: This was a single-center, comparative cohort study comprising 2 cohorts of patients treated for DD in 1 or more of 3 ulnar fingers with collagenase injection (159 patients) or surgical fasciectomy (59 patients). At 5 years after treatment, 13 collagenase-treated and 8 fasciectomy-treated patients had undergone subsequent treatment on the treated fingers and were considered to have current contracture. Of the remaining patients, 112 collagenase-treated patients (128 hands, 180 fingers) and 46 fasciectomy-treated patients (49 hands, 63 fingers) attended follow-up evaluation performed by 2 independent examiners (participation rate 84% and 93%, respectively). We defined current contracture in a treated finger as an active extension deficit of ≥20° in the metacarpophalangeal (MCP) or proximal interphalangeal (PIP) joint or a total (MCP + PIP) active extension deficit (TAED) of ≥30°. We used linear mixed models to analyze differences between the cohorts over time.
Results: In the collagenase cohort, current contracture was present in 45 (25%) MCP and 60 (33%) PIP joints, and in the fasciectomy cohort, current contracture was present in 12 MCP (19%) and 30 PIP (48%) joints; a TAED of ≥30° was present in 79 (44%) of the collagenase-treated and 30 (48%) of the fasciectomy-treated fingers. In MCP and PIP joints with ≥20° pretreatment contracture, complete correction was observed in 82 (56%) MCP and 30 (30%) PIP joints in the collagenase cohort and 23 (70%) MCP and 5 (16%) PIP joints in the fasciectomy cohort. There was no statistically significant difference between the 2 cohorts in the TAED change over time.
Conclusions: In patients with DD, collagenase injection and surgical fasciectomy improved finger joint contracture over the pretreatment status but had a high prevalence of joint contracture in the treated fingers 5 years after treatment.
Type of study/level of evidence: Therapeutic IV.
Keywords: Collagenase; Dupuytren contracture; fasciectomy.
Copyright © 2022. Published by Elsevier Inc.
Similar articles
-
Collagenase injections for Dupuytren disease: 3-year treatment outcomes and predictors of recurrence in 89 hands.Acta Orthop. 2019 Dec;90(6):517-522. doi: 10.1080/17453674.2019.1663472. Epub 2019 Sep 10. Acta Orthop. 2019. PMID: 31500473 Free PMC article.
-
Comparison between Collagenase Injection and Partial Fasciectomy in the Treatment of Dupuytren's Contracture.Hand Surg. 2015 Oct;20(3):386-90. doi: 10.1142/S0218810415500288. Hand Surg. 2015. PMID: 26387998
-
Surgical fasciectomy versus collagenase injection in treating recurrent Dupuytren disease: study protocol of a randomised controlled trial.BMJ Open. 2019 Feb 25;9(2):e024424. doi: 10.1136/bmjopen-2018-024424. BMJ Open. 2019. PMID: 30808670 Free PMC article. Clinical Trial.
-
Collagenase Treatment Versus Needle Fasciotomy for Single-Digit Dupuytren Contractures: A Meta-Analysis of Randomized Controlled Trials.J Hand Surg Am. 2023 Dec;48(12):1200-1209. doi: 10.1016/j.jhsa.2023.08.008. Epub 2023 Sep 16. J Hand Surg Am. 2023. PMID: 37725027
-
Outcomes of Management of Recurrent Dupuytren Contracture: A Systematic Review and Meta-analysis.Hand (N Y). 2022 Nov;17(6):1104-1113. doi: 10.1177/1558944721994220. Epub 2021 Feb 22. Hand (N Y). 2022. PMID: 33618538 Free PMC article.
Cited by
-
Clinical Outcomes of Collagenase Injections in Management of Dupuytren Contracture of the Proximal Interphalangeal Joint.J Hand Surg Glob Online. 2024 Jul 9;6(5):627-630. doi: 10.1016/j.jhsg.2024.05.009. eCollection 2024 Sep. J Hand Surg Glob Online. 2024. PMID: 39381385 Free PMC article.
-
Risk Factors for Long-Term Contracture Recurrence after Collagenase Injection for Dupuytren Disease: A Prospective Cohort Study.Biomedicines. 2023 Feb 24;11(3):699. doi: 10.3390/biomedicines11030699. Biomedicines. 2023. PMID: 36979678 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous